CenterWatch
  • Search Clinical Trials
  • Clinical Trial Listings
  • Volunteer
  • Learn About Clinical Trials

Amagasaki, Hyogo, Japan

< 2 Miles
Filters

Type

Distance
Age
0
0
Gender
Trial Phase
Sponsor
  • Study of Obeldesivir to Treat Children With Respiratory Syncytial Virus (RSV) Infection

    Pediatric participants will be enrolled as follows: - Cohort 1: Infants and children from 4 weeks postnatal age, weighing ≥ 1.5 kg to < 40 kg - Cohort 2: Neonates, either born at term or preterm, weighing ≥ 1.5 kg to < 6 kg

    Phase

    2

    Span

    61 weeks

    Sponsor

    Gilead Sciences

    Fukuoka

    Recruiting

  • Japanese Coronary Intervention Using Drug Eluting and Perfusion Therapy for Left Main Disease (JDEPTH-LM Registry)

    JDEPTH-LM Registry is a prospective observational multi-center study. The investigators will enroll and treat patients in the registry who meet the selection criteria under usual care and for whom PCI with W-KBT following on crossover stenting for LMT-LAD direction, proximal optimization technique (POT), and conventional kissing balloon technique (C-KBT) is the optimal treatment. The operators shall obtain oral or written consent from patients who meet the criteria before performing PCI, indicating the intention to perform PCI with W-KBT, and shall keep records. The investigators will continuously register cases attempting PCI with W-KBT according to the protocol and evaluate its efficacy and safety using data from this multi-center registry.

    Phase

    N/A

    Span

    292 weeks

    Sponsor

    TCROSS Co., Ltd.

    Fukuoka

    Recruiting

  • Study of Oral ABBV-932 to Assess Adverse Events and Change in Disease Activity in Adult Participants With Bipolar I or II Disorder

    Phase

    2

    Span

    81 weeks

    Sponsor

    AbbVie

    Fukuoka

    Recruiting

  • A Study of Valemetostat Tosylate Plus Pembrolizumab Versus Pembrolizumab Alone in First-Line NSCLC Without Actionable Genomic Alterations

    This trial will evaluate the safety and efficacy of valemetostat tosylate (DS-3201b) in combination with fixed-dose pembrolizumab versus pembrolizumab alone in participants with advanced or metastatic NSCLC without actionable genomic alterations, whose tumor has PD-L1 TPS ≥50%, and who have not received prior systemic therapy for advanced or metastatic NSCLC. The trial will be in 2 phases, dose escalation and dose expansion phases.

    Phase

    1/2

    Span

    287 weeks

    Sponsor

    Daiichi Sankyo

    Fukuoka

    Recruiting

  • Focused Research On Neurofeedback Therapy In Eradicating Depression (FRONTIER)

    Phase

    1/2

    Span

    71 weeks

    Sponsor

    UNB Sumiyoshi Jinja Mae Clinic

    Fukuoka

    Recruiting

  • A Study to Assess Efficacy and Safety of Efgartigimod PH20 SC in Adults With Ocular Myasthenia Gravis

    Phase

    3

    Span

    172 weeks

    Sponsor

    argenx

    Fukuoka

    Recruiting

  • Research Study in Japan to Compare Dasiglucagon With Glucagon in Treating Very Low Levels of Blood Sugar in Asian Adults With Type 1 Diabetes and Testing of Dasiglucagon for the Same Condition in Japanese Adolescents

    Phase

    1

    Span

    49 weeks

    Sponsor

    Novo Nordisk A/S

    Fukuoka

    Recruiting

  • Software as a Medical Device for the Treatment of Patients With PTSD

    Phase

    2/3

    Span

    179 weeks

    Sponsor

    Otsuka Medical Devices Co., Ltd. Japan

    Fukuoka

    Recruiting

  • A Study to Compare the Efficacy and Safety of Idecabtagene Vicleucel With Lenalidomide Maintenance Therapy Versus Lenalidomide Maintenance Therapy Alone in Adult Participants With Newly Diagnosed Multiple Myeloma Who Have Suboptimal Response After Autologous Stem Cell Transplantation

    Phase

    3

    Span

    455 weeks

    Sponsor

    Celgene

    Fukuoka

    Recruiting

  • A Study to Investigate the Effect of Lepodisiran on the Reduction of Major Adverse Cardiovascular Events in Adults With Elevated Lipoprotein(a) - ACCLAIM-Lp(a)

    Phase

    3

    Span

    265 weeks

    Sponsor

    Eli Lilly and Company

    Fukuoka

    Recruiting

1-10 of 183
CenterWatch

5000 Centregreen Way, Suite 200
Cary, NC, 27513, USA

Phone: 609.945.0101

  • Disclaimer
  • Privacy Policy
  • Term of Use
  • Do Not Sell My Personal Information